CARTER, Barry Howard, GlaxoSmithKline Corp. Int.,CAMPBELL, Dwayne A., GlaxoSmithKline Corp. Int.
申请号：
DK06750475
公开号：
DK1871347T3
申请日:
2006.04.18
申请国别(地区):
DK
年份:
2016
代理人:
摘要：
Oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
